in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
The Case for Outsourcing Peptides Manufacture
2:03 AM MDT | August 26, 2010
An article by the American Peptide Company (Sunnyvale, CA) These days, many companies facing increasing pressure, to reduce costs, risk, and time-to-market, and maximize efficiencies, have converged on a similar strategy: outsource non-core functions. This is why companies as small as start-up biotechs and as large as the pharmaceutical and biopharmaceutical majors, outsource peptide production needs ever more increasingly. Whether a company needs research-grade materials or GMP-grade materials, they are realizing cost effectiveness and efficiency by...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee